Annual Report

Total Page:16

File Type:pdf, Size:1020Kb

Annual Report Zilkha Neurogenetic Institute 2013-2014 annual report Table of Contents 2 Director’s Letter 3 History and Mission 4 ZNI Faculty 8 Faculty Research Programs 12 Scientific Advancements 23 Collaborations 37 Faculty News 41 Faculty Activities 43 Grants and Contracts 50 Special Lectures 51 4th Annual Zach Hall Lecture 52 1st Annual Zilkha Symposium on Alzheimer’s Disease & Related Disorders 54 Academic Activities 56 Neurodegeneration Journal Club/NRSA Grant Training 57 Los Angeles Brain Bee 58 Music to Remember - LA Opera/Alzheimer’s Association 59 ZNI Graduate Students 62 ZNI Postdoctoral Trainees 64 FY14 Faculty Publications 81 ZNI Administration 83 ZNI Development 1 Dear Friends, The World Health Organization estimates that devastating brain disorders and diseases affect more than one billion people worldwide. Last year, President Obama launched the BRAIN Initiative as a large-scale effort to equip researchers with fundamental insights necessary for treating a wide variety of brain disorders like Alzheimer’s, schizophrenia, autism, epilepsy, and traumatic brain injury. Research on the brain is surging. The United States and the European Union have launched new programs to better understand the brain. Scientists are mapping parts of mouse, fly and human brains at different levels of magnification. Technology for recording and imaging brain activity has been improving at a revolutionary pace. Yet the growing body of data—maps, atlases and so-called connectomes that show linkages between cells and regions of the brain— represents a paradox of progress, with the advances also highlighting great gaps in understanding. Specifically, interpreting these brain-wiring maps, and ultimately establishing the approach that physicians and scientists will use to treat neurological diseases, requires a clear understanding of brain circuitry, information that can only be obtained through basic research like the fine work being performed at ZNI. Scientists at ZNI are working harder than ever and achieving strong recognition for doing so. I am proud to say that of the 148 of papers published last year by our investigators, 17.5% were in high-impact journals, up 3.5% from last year. Similarly, despite the difficult funding climate, total grant dollars brought in by director’s letter director’s ZNI researchers is up 8.3% over last year. We also show in the following pages that ZNI investigators continue significant collaborations across USC, the region and around the world. This is great science. As ZNI investigators deploy novel approaches to examine and understand the underlying structure of and relationships between the various components that comprise the nervous system, we are driving translational research more and more toward transformative medicine. Please join us on this exciting road of discovery. All the best, “The human brain is the most complicated biological structure in the known universe. We’ve only just scratched the surface in understanding how it works or, unfortunately, doesn’t quite work when disorders and disease occur.” —Francis S. Collins MD PhD, Director, National Institutes of Health (NIH) 2 History and Mission With the support of the WM Keck Foundation and a generous gift from Mr Selim Zilkha, the Zilkha Neurogenetic Institute (ZNI) broke ground in more than one way just over 12 years ago. Some questioned why a new institute devoted to nurturing the best basic scientists would be located on a medical campus. But as entrepreneurs like Mr Zilkha know all too well, cutting-edge endeavors frequently receive considerable scrutiny and he and the Keck School of Medicine of USC persevered. Now with more than 30 laboratories populated by hundreds of researchers, ZNI is fast becoming the hub of the USC neuroscience community. Clinicians, physician scientists along with researchers and trainees at all levels—from undergraduate to graduate to postdoctoral—are forging collaborations across departments, disciplines and schools. And we are beginning to see other universities follow this model, aligning traditional wet lab research space directly amid their clinical operations. With the feedback between physicians and scientists, the work at ZNI is aimed to identify those at risk, promote preventive measures, develop innovative therapies and ultimately discover and translate cures from bench to bedside, for a spectrum of devastating brain disorders from Alzheimer’s disease to schizophrenia. However, despite the major advances that science is making in understanding how the human brain works, some neurodegenerative disorders and psychiatric conditions are on the rise and becoming more frequent, outpacing diagnostic and treatment approaches. Only if scientists like those working at ZNI continue to devote their efforts toward their areas of research, if they have access to significant funding, and if robust collaborations on Alzheimer’s and other brain diseases endure, only then will our efforts eventually lead to preventive approaches that could reduce memory loss and other serious symptoms that occur as a result of brain diseases. Alzheimer’s is the sixth-leading cause of death in the country and the only cause of death among the top 10 in the United States that cannot be prevented, cured or even slowed. 3 ZNI Faculty Alexandre Bonnin PhD Robert H. Chow MD, PhD Assistant Professor Associate Professor Cell & Neurobiology Physiology & Biophysics Daniel B. Campbell PhD Marcelo Coba PhD Assistant Professor Assistant Professor Psychiatry & the Behavorial Sciences Psychiatry & the Behavioral Sciences Karen Chang PhD David V. Conti PhD Assistant Professor Professor Cell & Neurobiology Preventive Medicine Jeannie Chen PhD Zemin Deng PhD Professor Assistant Professor of Research Cell & Neurobiology Psychiatry & the Behavioral Sciences 4 Hong-Wei Dong MD, PhD Radha Kalluri PhD Associate Professor Assistant Professor of Research Neurology Otolaryngology Oleg Evgrafov PhD James A. Knowles MD, PhD Associate Professor of Research Professor Psychiatry & the Behavioral Sciences Psychiatry & the Behavioral Sciences Greg Field PhD Ralf Langen PhD Assistant Professor Professor Cell & Neurobiology Biochemistry & Molecular Biology Rick A. Friedman MD, PhD Le Ma PhD Professor Assistant Professor of Research Otolaryngology Cell & Neurobiology 5 William Mack MD Janos Peti-Peterdi MD, PhD Assistant Professor Professor Neurological Surgery Physiology & Biophysics Takahiro Ohyama PhD Alapakkam Sampath PhD Assistant Professor of Research Associate Professor Otolaryngology Physiology & Biophysics Carlos Pato MD, PhD Derek Sieburth PhD Professor & Chair Associate Professor Psychiatry & the Behavioral Sciences Cell & Neurobiology Michele Pato MD Ansgar Siemer PhD Professor Assistant Professor Psychiatry & the Behavioral Sciences Biochemistry & Molecular Biology 6 Huizhong W. Tao PhD Gabriel Zada MD Associate Professor Assistant Professor Cell & Neurobiology Neurological Surgery Terrence Town PhD Li Zhang PhD Professor Associate Professor Physiology & Biophysics Physiology & Biophysics Kai Wang PhD Berislav V. Zlokovic MD, PhD Assistant Professor Director, Zilkha Neurogenetic Institute Psychiatry & the Behavioral Sciences Professor & Chair Physiology & Biophysics Tobias S. Ulmer PhD Associate Professor Biochemistry & Molecular Biology ZNI Faculty 7 Faculty Research Programs Scientists at the Zilkha Neurogenetic Institute reach across boundaries to embrace methods and techniques from many fields of study. They work to identify new approaches for examining nervous system function, so we may all better understand the underlying causes of neurological and psychiatric disorders. Areas of research overlap considerably (e.g., vision and circuits), and every Principal Investigator (PI) has multiple projects ongoing at any one time. Here is an overview of the current topics of study with related examples: Alzheimer and Related Diseases The Protein Structure group (Drs Ralf Langen, Ansgar Siemer and Tobias Ulmer) investigate the structure of proteins involved in debilitating diseases such as Alzheimer’s disease (AD) but also Parkinson’s and Huntington’s disease. Because many disorders of the nervous system are thought to arise from alterations in the structure of cellular proteins, these studies aim to help us understand the molecular basis of neural pathology, with a look toward devising new treatments for the cure and prevention of these diseases. Dr Karen Chang’s lab is trying to determine the role nebula/DSCR1 plays in ameliorating axonal transport defects and memory loss associated with Alzheimer’s disease; relatedly her group is trying to identify the genotype to phenotype correlations in Down syndrome. Dr Jeannie Chen is studying how Annexin A5 modifies disease progression in a mouse model for Alzheimer’s disease. Dr Hong-Wei Dong’s lab is studying the organizational principle of the brain wiring and how these circuits are disrupted in mouse models of Huntington’s and Alzheimer’s diseases. Dr Terrence Town and his team are developing new animal models of Alzheimer’s disease and related disorders to study the role of the immune system in dementia and other devastating disorders of the mind. Dr Berislav Zlokovic’s laboratory has a long standing interest in understanding the role of cerebral blood vessels and blood-brain barrier (BBB) in pathogenesis of neurodegenerative disorders such as Alzheimer’s disease and more recently amytrophic lateral sclerosis, as foundations for development of new therapies for AD and related neurodegenerative disorders as well as stroke.
Recommended publications
  • The Epistemology of Evidence in Cognitive Neuroscience1
    To appear in In R. Skipper Jr., C. Allen, R. A. Ankeny, C. F. Craver, L. Darden, G. Mikkelson, and R. Richardson (eds.), Philosophy and the Life Sciences: A Reader. Cambridge, MA: MIT Press. The Epistemology of Evidence in Cognitive Neuroscience1 William Bechtel Department of Philosophy and Science Studies University of California, San Diego 1. The Epistemology of Evidence It is no secret that scientists argue. They argue about theories. But even more, they argue about the evidence for theories. Is the evidence itself trustworthy? This is a bit surprising from the perspective of traditional empiricist accounts of scientific methodology according to which the evidence for scientific theories stems from observation, especially observation with the naked eye. These accounts portray the testing of scientific theories as a matter of comparing the predictions of the theory with the data generated by these observations, which are taken to provide an objective link to reality. One lesson philosophers of science have learned in the last 40 years is that even observation with the naked eye is not as epistemically straightforward as was once assumed. What one is able to see depends upon one’s training: a novice looking through a microscope may fail to recognize the neuron and its processes (Hanson, 1958; Kuhn, 1962/1970).2 But a second lesson is only beginning to be appreciated: evidence in science is often not procured through simple observations with the naked eye, but observations mediated by complex instruments and sophisticated research techniques. What is most important, epistemically, about these techniques is that they often radically alter the phenomena under investigation.
    [Show full text]
  • Outlook Magazine, Autumn 2018
    Washington University School of Medicine Digital Commons@Becker Outlook Magazine Washington University Publications 2018 Outlook Magazine, Autumn 2018 Follow this and additional works at: https://digitalcommons.wustl.edu/outlook Recommended Citation Outlook Magazine, Autumn 2018. Central Administration, Medical Public Affairs. Bernard Becker Medical Library Archives. Washington University School of Medicine, Saint Louis, Missouri. https://digitalcommons.wustl.edu/outlook/188 This Article is brought to you for free and open access by the Washington University Publications at Digital Commons@Becker. It has been accepted for inclusion in Outlook Magazine by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. AUTUMN 2018 Elevating performance BERNARD BECKER MEDICAL LIBRARY BECKER BERNARD outlook.wustl.edu Outlook 3 Atop the Karakoram Mountains, neurologist Marcus Raichle, MD, (center) displays a Mallinckrodt Institute of Radiology banner he created. In 1987, he and other members of a British expedition climbed 18,000 feet above sea level — and then injected radioactive xenon to see how it diffused through their brains. Raichle, 81, has been a central force for decades in the history and science of brain imaging. See page 7. FEATURES MATT MILLER MATT 7 Mysteries explored Pioneering neurologist Marcus Raichle, MD, opened up the human brain to scientific investigation. 14 Growing up transgender The Washington University Transgender Center helps families navigate the complex world of gender identity. COVER Scott Brandon, who sustained a spinal cord injury 16 years ago, said he is 21 Building independence grateful to the Program in Occupational For 100 years, the Program in Occupational Therapy has Therapy for helping him build physical and helped people engage mind and body.
    [Show full text]
  • FALL 2018 MSK Takes a Lead Role in Interventional Oncology FSFOCAL
    FOCAL SPOT FS FALL 2018 MSK Takes a Lead Role in Interventional Oncology MALLINCKRODT INSTITUTE OF RADIOLOGY // WASHINGTON UNIVERSITY // ST. LOUIS CONTENTS 10 A look at 10 MIR professors RAD who are helping lead the way for women in radiology. (From left: Geetika Khanna, MD, Pamela K. WOMEN Woodard, MD, and Farrokh Dehdashti, MD) 6 16 20 LIFE-ALTERING MYSTERIES MIR ALUMNI TREATMENT EXPLAINED WEEKEND MSK imaging chief Jack Jennings, Thirty years later, Marcus E. Raichle, Old friends, new stories and a sweet MD, provides quality-of-life improving MD, remains a central figure in the serenade from Ronald G. Evens, MD. procedures for patients with cancer. science of brain imaging. Inside MIR’s first reunion. Cover Photo: Metastatic melanoma patient Chris Plummer still works his farm every day, thanks to treatment resulting in unprecedented control of his tumors. 2 SPOT NEWS 24 ALUMNI SPOTLIGHT FOCAL SPOT MAGAZINE FALL 2018 Editor: Marie Spadoni Photography: Mickey Wynn, Daniel Drier Design: Kim Kania YI F A LOOK BACK ©2018 Mallinckrodt Institute of Radiology 26 28 mir.wustl.edu FOCAL SPOT MAGAZINE // 1 SPOT NEWS David H. Ballard, MD, a TOP-TIER participant, uses 3D printing in his translational imaging work. Training the Next Generation of Imaging Scientists by Kristin Rattini For young scientists eager to make their way to the forefront in clinical translational imaging research and bringing of translational research and precision imaging, Mallinckrodt innovation to the practice of medicine. The interdisciplinary Institute of Radiology (MIR) offers a clear path. A leader in grant provides two training slots per year in years one NIH funding, MIR is home to premier training programs and and two, and three slots in years three through five.
    [Show full text]
  • Reviewers [PDF]
    The Journal of Neuroscience, January 2013, 33(1) Acknowledgement For Reviewers 2012 The Editors depend heavily on outside reviewers in forming opinions about papers submitted to the Journal and would like to formally thank the following individuals for their help during the past year. Kjersti Aagaard Frederic Ambroggi Craig Atencio Izhar Bar-Gad Esther Aarts Céline Amiez Coleen Atkins Jose Bargas Michelle Aarts Bagrat Amirikian Lauren Atlas Steven Barger Lawrence Abbott Nurith Amitai David Attwell Cornelia Bargmann Brandon Abbs Yael Amitai Etienne Audinat Michael Barish Keiko Abe Martine Ammasari-Teule Anthony Auger Philip Barker Nobuhito Abe Katrin Amunts Vanessa Auld Neal Barmack Ted Abel Costas Anastassiou Jesús Avila Gilad Barnea Ute Abraham Beau Ances Karen Avraham Carol Barnes Wickliffe Abraham Richard Andersen Gautam Awatramani Steven Barnes Andrey Abramov Søren Andersen Edward Awh Sue Barnett Hermann Ackermann Adam Anderson Cenk Ayata Michael Barnett-Cowan David Adams Anne Anderson Anthony Azevedo Kevin Barnham Nii Addy Clare Anderson Rony Azouz Scott Barnham Arash Afraz Lucy Anderson Hiroko Baba Colin J. Barnstable Ariel Agmon Matthew Anderson Luiz Baccalá Scott Barnum Adan Aguirre Susan Anderson Stephen Baccus Ralf Baron Geoffrey Aguirre Anuska Andjelkovic Stephen A. Back Pascal Barone Ehud Ahissar Rodrigo Andrade Lars Bäckman Maureen Barr Alaa Ahmed Ole Andreassen Aldo Badiani Luis Barros James Aimone Michael Andres David Badre Andreas Bartels Cheryl Aine Michael Andresen Wolfgang Baehr David Bartés-Fas Michael Aitken Stephen Andrews Mathias Bähr Alison Barth Elias Aizenman Thomas Andrillon Bahador Bahrami Markus Barth Katerina Akassoglou Victor Anggono Richard Baines Simon Barthelme Schahram Akbarian Fabrice Ango Jaideep Bains Edward Bartlett Colin Akerman María Cecilia Angulo Wyeth Bair Timothy Bartness Huda Akil Laurent Aniksztejn Victoria Bajo-Lorenzana Marisa Bartolomei Michael Akins Lucio Annunziato David Baker Marlene Bartos Emre Aksay Daniel Ansari Harriet Baker Jason Bartz Kaat Alaerts Mark S.
    [Show full text]
  • Medicine@Yale U
    @ MedicineAdvancing Biomedical Science, Education and Health Care YaleVolume 4, Issue 3 July/August 2008 Leading scientist is appointed new chair of Cell Biology Membrane traffi c expert and chair of the School of Medicine’s to Yale’s recently protein-coding genes in the human Department of Cell Biology. Roth- opened West Cam- genome, providing fresh insights into will head a department man will come to Yale from Columbia pus in West Haven, disease and new molecular targets for that has shaped the fi eld University’s College of Physicians and Conn., where he will therapy. Under Rothman’s leadership Surgeons, where he is now a professor launch a Center for the Department of Cell Biology will James E. Rothman, F>:, one of the in the Department of Physiology and High-Throughput be signifi cantly expanded, and will be world’s foremost experts on mem- Biophysics, the Clyde and Helen Wu Cell Biology. At the co-located at the West Campus along brane traffi cking, the means by which Professor of Chemical Biology and new center, multi- with its present location at the main proteins and other materials are director of the Columbia Genome +BNFT3PUINBO disciplinary teams campus of the School of Medicine. transported within and between cells, Center. of scientists will develop tools and For his decades of seminal re- has been named the Fergus F. Wal- In addition to directing Cell techniques to rapidly decipher the cel- search on the transport of molecules lace Professor of Biomedical Sciences Biology, Rothman is the fi rst recruit lular functions of the
    [Show full text]
  • Otology & Neurotology
    Otology & Neurotology 2017 Journal Citation Report® (Clarivate, 2018) 2017 Journal Citation Reports® -- Key Metrics 2016 2017 Impact Factor 2.024 2.182 5-Year Impact Factor 2.163 2.264 Immediacy Index 0.326 0.194 Citable Items 279 309 Total Cites 6,695 7,427 Cited Half-life 6.3 6.7 Citing Half-life 9.2 9.1 Eigenfactor™ Score .01216 .01161 Article Influence™ Score .595 .584 Category Ranking Clinical Neurology 121/194 121/197 Otorhinolaryngology 13/42 13/41 2017 Impact Factor calculation Cites in 2017 to items published in: 2016 = 505 Number of items published in: 2016 = 279 2015 = 763 2015 = 302 Sum: 1268 Sum: 581 Calculation: Cites to recent items 1268 = 2.182 Number of recent items 581 2017 5-year Impact Factor calculation Cites in 2017 to items published in: 2016 = 505 Number of items published in: 2016 = 279 2015 = 763 2015 = 302 2014 = 758 2014 = 330 2013 = 629 2013 = 266 2012 = 609 2012 = 265 Sum: 3264 Sum: 1442 Calculation: Cites to recent items 3264 = 2.264 Number of recent items 1442 2017 Immediacy Index calculation Cites in 2017 to items published in 2017 = 60 Number of items published in 2017 = 309 Calculation: Cites to current items 60 = 0.194 Number of current items 309 Impact Factor: 2013- 2017 2013 2014 2015 2016 2017 Citations 834 949 1164 1279 1268 Articles 522 531 596 632 581 Impact Factor 1.598 1.787 1.953 2.024 2.182 Citations Articles Impact Factor 1400 2.5 2.182 1200 1.953 2.024 1.787 2 1000 1.598 Factor Impact 800 1.5 600 1 400 0.5 200 0 0 2013 2014 2015 2016 2017 Category Ranking: 2013-2017 Category 2013 2014 2015 2016 2017 Clinical Neurology 135/194 122/192 115/193 121/194 121/197 Otorhinolaryngology 15/44 17/44 13/43 13/42 13/41 Journal Self Cites Self Cites 1141(15.363% of 7427) Self Cites to Years Used in Impact Factor Calculation 246(19.401% of 1268) Impact Factor without Self Cites 1.759 Top Cited Papers in 2017 Published in 2015-2016 Cites Pub In Total Rank Title Authors Year Vol Iss 2017 Cites Epidemiology of Balance Symptoms and Disorders in the Community: A Murdin, Louisa; Schilder, Anne G.
    [Show full text]
  • Scope of Practice in Audiology
    SCOPE OF PRACTICE IN AUDIOLOGY AD HOC COMMITTEE ON THE SCOPE OF PRACTICE IN AUDIOLOGY Reference this material as: American Speech-Language-Hearing Association. (2018). Scope of Practice in Audiology [Scope of Practice]. Available from www.asha.org/policy. © Copyright 2018 American Speech Language Hearing Association. All rights reserved. Disclaimer: The American Speech-Language-Hearing Association disclaims any liability to any party for the accuracy, completeness, or availability of these documents, or for any damages arising out of the use of the documents and any information they contain. Scope of Practice in Audiology ABOUT THIS DOCUMENT This scope of practice document is an official policy of the American Speech-Language-Hearing Association (ASHA) defining the breadth of practice within the profession of audiology. The Audiology Scope of Practice document has not been updated since 2004. The aim of this document is to reflect the current and evolving clinical practice in audiology. Such changes include, but are not limited to, telehealth, discussion of hearing technologies beyond traditional hearing devices (e.g., over-the-counter [OTC]), and personal sound amplification products (PSAPs). Additional updates in advancements in hearing device implantation, vestibular assessment and rehabilitation, hearing preservation, educational audiology, and interoperative monitoring practice are included. This document was developed by the ASHA Ad Hoc Committee on the Scope of Practice in Audiology. Committee members were Julie Honaker (chair), Robert Beiter, Kathleen Cienkowski, Gregory Mannarelli, Maryrose McInerney, Tena McNamara, Jessica Sullivan, Julie Verhoff, Robert Fifer (board liaison), and Pam Mason (ex officio). This document was approved by the ASHA Board of Directors on August 20, 2018.
    [Show full text]
  • Uva-DARE (Digital Academic Repository)
    UvA-DARE (Digital Academic Repository) The space inside the skull : digital representations, brain mapping and cognitive neuroscience in the decade of the brain Beaulieu, J.A. Publication date 2000 Link to publication Citation for published version (APA): Beaulieu, J. A. (2000). The space inside the skull : digital representations, brain mapping and cognitive neuroscience in the decade of the brain. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:30 Sep 2021 Workss Cited Ahhot.. Allison 19922 Confusion about form and function clouds launch of EC's Decade of ihe Brain. Nature. 24 September.. 359: 260. Ackerman.. Sandra 19922 The Role of the Brain in Mental Illness. !n Discovering the Brain. 46-66. Washington. DC:: National Academy Press.
    [Show full text]
  • Learning Disabilities
    LEARNING DISABILITIES Edited by Wichian Sittiprapaporn LEARNING DISABILITIES Edited by Wichian Sittiprapaporn Learning Disabilities Edited by Wichian Sittiprapaporn Published by InTech Janeza Trdine 9, 51000 Rijeka, Croatia Copyright © 2012 InTech All chapters are Open Access distributed under the Creative Commons Attribution 3.0 license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. After this work has been published by InTech, authors have the right to republish it, in whole or part, in any publication of which they are the author, and to make other personal use of the work. Any republication, referencing or personal use of the work must explicitly identify the original source. As for readers, this license allows users to download, copy and build upon published chapters even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. Notice Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials, instructions, methods or ideas contained in the book. Publishing Process Manager Martina Durovic Technical Editor Teodora Smiljanic Cover Designer InTech Design Team First published March, 2012 Printed in Croatia A free online edition of this book is available at www.intechopen.com Additional hard copies can be obtained from [email protected] Learning Disabilities, Edited by Wichian Sittiprapaporn p.
    [Show full text]
  • Giovanni Berlucchi
    BK-SFN-NEUROSCIENCE-131211-03_Berlucchi.indd 96 16/04/14 5:21 PM Giovanni Berlucchi BORN: Pavia, Italy May 25, 1935 EDUCATION: Liceo Classico Statale Ugo Foscolo, Pavia, Maturità (1953) Medical School, University of Pavia, MD (1959) California Institute of Technology, Postdoctoral Fellowship (1964–1965) APPOINTMENTS: University of Pennsylvania (1968) University of Siena (1974) University of Pisa (1976) University of Verona (1983) HONORS AND AWARDS: Academia Europaea (1990) Accademia Nazionale dei Lincei (1992) Honorary PhD in Psychology, University of Pavia (2007) After working initially on the neurophysiology of the sleep-wake cycle, Giovanni Berlucchi did pioneering electrophysiological investigations on the corpus callosum and its functional contribution to the interhemispheric transfer of visual information and to the representation of the visual field in the cerebral cortex and the superior colliculus. He was among the first to use reaction times for analyzing hemispheric specializations and interactions in intact and split brain humans. His latest research interests include visual spatial attention and the representation of the body in the brain. BK-SFN-NEUROSCIENCE-131211-03_Berlucchi.indd 97 16/04/14 5:21 PM Giovanni Berlucchi Family and Early Years A man’s deepest roots are where he has spent the enchanted days of his childhood, usually where he was born. My deepest roots lie in the ancient Lombard city of Pavia, where I was born 78 years ago, on May 25, 1935, and in that part of the province of Pavia that lies to the south of the Po River and is called the Oltrepò Pavese. The hilly part of the Oltrepò is covered with beautiful vineyards that according to archaeological and historical evidence have been used to produce good wines for millennia.
    [Show full text]
  • Consolidated Annual Activities Report for 2014
    CONSOLIDATED ANNUAL ACTIVITIES REPORT FOR 2014 ‘The Academy of Europe’ Registered office Room 251, Senate House, Malet Street, London WC1E 7HU Tele: +44 (0) 20 7862 5784 Email: [email protected] Web: http://www.ae-info.org Company limited by Guarantee and registered at Companies House. Registration number 7028223 Registered with the Charity Commission, registration number 1133902 1 THE TRUSTEES, AND COUNCIL OF THE ACADEMIA EUROPAEA Board of TRUSTEES (at 31 December 2014) President: Professor Sierd Cloetingh Utrecht, (elected June 2014) Professor Lars Walløe Oslo (till AGM July 2014) Vice President: Professor Anne Buttimer Dublin, (till 2015 eligible for re- election) Vice President: Professor Sierd Cloetingh (till AGM 2014) Hon. Treasurer: (from January 2010) Professor Sir Roger Elliott Oxford, (till 2015) Co-opted Members: Professor Jerzy Langer Warsaw (resigned April 2014) Professor Andreu Mas Colell Barcelona (resigned June 2014) Professor Theo D’haen Leuven, (till 2015) Professor Ole Petersen Cardiff, (till 2015) Professor Hermann Maurer Graz, (till end 2015) Appointed by Council: Professor Balazs Gulyas Stockholm, (re-appointed, AGM 2013 – Dec. 2016) Professor Don Dingwell Munich, (appointed, Jan 2014, eligible for re-appointment) Professor Svend Erik Larsen Copenhagen, (appointed, Jan. 2014, eligible for re-appointment) At the time of writing this report, the number of independent members elected to Council was set at a maximum of three. The Chairs of the Academic Sections are de facto members of the Council. Periods of office of Section chairs are as described in the regulations. The list of Section chairs, as at 31 December 2014, is at annex 1a of this report. Three members of the Council are nominated to the Board of Trustees.
    [Show full text]
  • Natural Cures "They" DonT Want You to Know About
    Natural Cures "They" Dont Want You to Know About KEVIN TRUDEAU Alliance Publishing Group, Inc. Natural Cures "They" Dont Want You to Know About Natural Cures "They" Don't Want You to Know About Copyright ©2004 by Kevin Trudeau All rights reserved. This edition published by Alliance Publishing Group, Inc. For information, address: Alliance Publishing Group, Inc. P.O. Box 207 Elk Grove Village, IL 60009 Published in the United States of America. No part of this book may be used or reproduced in any manner whatsoever without the written permission of the publisher. ISBN 0-9755995- 1 -8 Library of Congress Control Number: 2005925679 Manufactured in the United States of America 10 9 8 7 6 5 4 RRD Contents Disclaimer vii Acknowledgments ix Read This First xi Introduction xiii 1 I Should Be Dead By Now 1 2 Whats Wrong with Health Care in America? 9 3 Its All About the Money 13 4 Who Are "They"? 21 5 Why Are We Sick? 67 6 How to Never Get Sick Again 115 7 Why People Are Fat 179 8 How to Lose Weight Effortlessly and Keep It Off Forever 189 9 How to Read Food Labels 199 10 Not Convinced? 219 11 Frequently Asked Questions 293 12 Still Not Convinced? 319 13 "Natural" Cures for Specific Diseases 341 14 Naturalcures.com 359 15 The Solution 369 Appendix A Free Bonus Materials: Newsletter Articles 379 Appendix B No-Hunger Bread: A True FDA Horror Story 463 Appendix C How to Find a Health-care Practitioner 565 About the Author 571 All of the authors royalties on the sale of this book are being used to help fund the mission of educating people about natural health care and exposing corporate and government corruption.
    [Show full text]